Search Results - R. A. Khamitov

  • Showing 1 - 16 results of 16
Refine Results
  1. 1
    To readers

    To readers by R. A. Khamitov

    Published 2024-07-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Implementation of the quality-by-design concept for an adeno-associated viral vector-based gene therapy

    Implementation of the quality-by-design concept for an adeno-associated viral vector-based gene therapy by D. S. Kopein, G. N. Poroshin, R. A. Khamitov

    Published 2025-06-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Prospects for Using the ELISPOT Technological Platform as Part of Anti-Epidemic Measures Against the New Coronavirus Infection COVID-19

    Prospects for Using the ELISPOT Technological Platform as Part of Anti-Epidemic Measures Against the New Coronavirus Infection COVID-19 by D. A. Poteryaev, R. A. Khamitov, G. A. Efimov, A. M. Shuster

    Published 2020-09-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    Methodological Approaches to Validation of Therapeutic Recombinant Proteins Production Based on the Quality by Design Concept

    Methodological Approaches to Validation of Therapeutic Recombinant Proteins Production Based on the Quality by Design Concept by N. V. Stratonova, A. S. Lisov, A. N. Morozov, D. V. Tyupa, R. A. Khamitov

    Published 2018-09-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    Analysis of Arbidol® Effectiveness agains an Experimental Form of Severe Acute Respiratory Syndrome

    Analysis of Arbidol® Effectiveness agains an Experimental Form of Severe Acute Respiratory Syndrome by S. Ya. Loginova, V. N. Shchukina, S. V. Borisevich, R. A. Khamitov, V. A. Maksimov, A. M. Shuster

    Published 2020-05-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    Assessment of T-cell immunity to SARS-CoV-2 in COVID-19 convalescents and vaccinated subjects, using TigraTest<sup>®</sup> SARS-CoV-2 ELISPOT kit

    Assessment of T-cell immunity to SARS-CoV-2 in COVID-19 convalescents and vaccinated subjects, using TigraTest<sup>®</sup> SARS-CoV-2 ELISPOT kit by D. A. Poteryaev, S. G. Abbasova, P. E. Ignatyeva, O. M. Strizhakova, S. V. Kolesnik, R. A. Khamitov

    Published 2021-10-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    Validation of a test procedure for determination of specific activity of human recombinant interferon beta (Infibeta®) using various cell/virus combinations

    Validation of a test procedure for determination of specific activity of human recombinant interferon beta (Infibeta®) using various cell/virus combinations by Yu. N. Lebedeva, N. A. Litvinova, T. N. Lobanova, R. R. Shukurov, R. A. Khamitov, L. A. Gaiderova

    Published 2022-04-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    Comparative safety evaluation of intranasal and intramuscular immunisation with Ad26 and Ad5-vectored vaccines to prevent coronavirus infection

    Comparative safety evaluation of intranasal and intramuscular immunisation with Ad26 and Ad5-vectored vaccines to prevent coronavirus infection by E. V. Zuev, O. L. Evdokimova, O. A. Markova, I. A. Korotkevich, T. V. Grigorieva, R. A. Khamitov

    Published 2023-10-01
    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    Physico-Chemical and Biological Properties of Biosimilar and Reference Tissue Plasminogen Activator Products

    Physico-Chemical and Biological Properties of Biosimilar and Reference Tissue Plasminogen Activator Products by V. D. Gusarova, M. S. Pantyushenko, V. M. Simonov, R. R. Shukurov, R. A. Khamitov, A. Yu. Vishnevskiy

    Published 2019-03-01
    Get full text
    Article

    Save to List
    Saved in:
  10. 10
    An experience of scaling and intensifying the industrial production of the Gam-COVID-Vac vector adenovirus vaccine in the limiting conditions of the pandemic

    An experience of scaling and intensifying the industrial production of the Gam-COVID-Vac vector adenovirus vaccine in the limiting conditions of the pandemic by A. N. Morozov, I. R. Yakhin, N. V. Stratonova, M. V. Kutskir, D. A. Poteryaev, R. A. Khamitov

    Published 2022-12-01
    Get full text
    Article

    Save to List
    Saved in:
  11. 11
    Optimisation of culture conditions for a producer clone coexpressing arylsulfatase B and a formylglycine-generating enzyme in order to increase the yield of arylsulfatase B

    Optimisation of culture conditions for a producer clone coexpressing arylsulfatase B and a formylglycine-generating enzyme in order to increase the yield of arylsulfatase B by S. S. Timonova, K. A. Smolova, I. A. Kirik, M. S. Pantyushenko, R. L. Anisimov, R. A. Khamitov, A. A. Piskunov, V. N. Bade

    Published 2022-10-01
    Get full text
    Article

    Save to List
    Saved in:
  12. 12
    Increasing productivity of arylsulfatase B-producing cell line by coexpression of formylglycine-generating enzyme

    Increasing productivity of arylsulfatase B-producing cell line by coexpression of formylglycine-generating enzyme by S. S. Timonova, K. A. Smolova, D. T. Zaripova, M. S. Pantyushenko, M. A. Koroleva, R. L. Anisimov, R. A. Khamitov, A. A. Piskunov, V. N. Bade

    Published 2022-04-01
    Get full text
    Article

    Save to List
    Saved in:
  13. 13
    The Creation of Technological Lines for the Cultivation of Modified Lines of Mammalian Cells Expressing Recombinant Proteins

    The Creation of Technological Lines for the Cultivation of Modified Lines of Mammalian Cells Expressing Recombinant Proteins by I. A. Churkin, S. V. Borisevich, D. A. Kutaev, V. T. Lymar, Yu. I. Pashchenko, E. V. Gordeev, V. S. Kulish, T. M. Plekhanova, R. A. Khamitov, E. N. Sautkina

    Published 2023-06-01
    Get full text
    Article

    Save to List
    Saved in:
  14. 14
    Development of cell lines producing recombinant therapeutic proteins, with denosumab as a case study

    Development of cell lines producing recombinant therapeutic proteins, with denosumab as a case study by S. S. Timonova, I. A. Kirik, M. A. Filatova, A. I. Anfilatova, S. S. Shubina, A. A. Polupanova, A. F. Gabdrakhmanova, E. S. Ivanov, V. N. Bade, A. A. Piskunov, R. A. Khamitov

    Published 2022-03-01
    Get full text
    Article

    Save to List
    Saved in:
  15. 15
    Development and certification of an industrial reference standard for determination of filgrastim activity

    Development and certification of an industrial reference standard for determination of filgrastim activity by E. V. Motuzova, N. A. Alpatova, L. A. Gayderova, O. B. Runova, R. A. Volkova, E. D. Mytsa, V. P. Bondarev, A. A. Wainson, V. V. Mesherikova, R. A. Khamitov

    Published 2018-02-01
    Get full text
    Article

    Save to List
    Saved in:
  16. 16
    Comparative study of the clinical efficacy of the first domestic bioanalogue of tocilizumab based on the results of a randomized clinical trial of phase III

    Comparative study of the clinical efficacy of the first domestic bioanalogue of tocilizumab based on the results of a randomized clinical trial of phase III by E. V. Akatova, Yu. S. Bakhareva, O. V. Bugrova, I. B. Vinogradova, E. V. Gerasimova, Yu. E. Drevina, O. B. Ershova, E. V. Zonova, Yu. I. Ivanova, E. P. Ilivanova, M. M. Kostik, D. G. Krechikova, D. A. Kusevich, A. L. Maslyansky, A. D. Meshkov, N. S. Mosesova, K. A. Nagornova, D. V. Nosovich, S. A. Polyakova, T. A. Popova, E. A. Smolyarchuk, V. N. Sorotskaya, Yu. G. Shvarts, L. N. Shilova, M. S. Shostak, I. Yu. Yunonin, N. E. Akhtyamova-Givirovskaya, R. A. Khamitov, O. A. Markova, E. I. Zagoruiko, E. V. Zuev

    Published 2024-12-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: